3 new MS drug trials-all address blood flow

A forum to discuss Chronic Cerebrospinal Venous Insufficiency and its relationship to Multiple Sclerosis.

3 new MS drug trials-all address blood flow

Postby cheerleader » Sun May 17, 2015 12:13 pm

Three new MS drug trials in the press this month.

If you ever wondered whether blood flow was important to brain health, all you would have to do is read about three new MS drug trials announced in the past month.

All three of these compounds have been shown in animal models of MS to reduce symptoms, reduce relapses and slow progression. All three have been touted as "neuroprotective."

And all three of these medications have a very similar method of action (MOA) in humans. All have been used for years for cardiovascular and stroke patients. All have an effect on the endothelium and release nitric oxide and lower blood pressure. All three deal with "hypoperfusion", or reduced blood flow.

They all widen blood vessels, and increase blood flow to and from the brain.

guanabenz-- relaxes blood vessels so that blood may pass through more easily.
http://www.mayoclinic.org/drugs-supplem ... g-20064106

ibudilast-- increases cerebral blood flow, is a vasodilator

biotin---decreases blood pressure, increases blood flow, treats ischemia (low O2) after stroke

more info here:
http://ccsviinms.blogspot.com/2015/05/b ... tters.html

Husband dx RRMS 3/07
dx dual jugular vein stenosis (CCSVI) 4/09
User avatar
Family Elder
Posts: 5358
Joined: Mon Sep 10, 2007 2:00 pm
Location: southern California


Return to Chronic Cerebrospinal Venous Insufficiency (CCSVI)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service